Intervention (n=1019) | Usual care subsample (n=252) | Usual care all (n=1005) | Statistical test* (Int. vs. UC subsample) | Statistical test* (Int. vs. UC all) | |
---|---|---|---|---|---|
Country | |||||
Denmark | 104 (10.2%) | 40 (15.9%) | 154 (15.3%) | p=0.012 | p<0.001 |
Italy | 165 (16.2%) | 47 (18.7%) | 194 (19.3%) | ||
Netherlands | 191 (18.7%) | 37 (14.7%) | 123 (12.2%) | ||
Poland | 234 (23.0%) | 45 (17.9%) | 160 (15.9%) | ||
Spain | 199 (19.5%) | 41 (16.3%) | 193 (19.2%) | ||
UK | 126 (12.4%) | 42 (16.7%) | 181 (18.0%) | ||
Gender | |||||
Male | 507 (49.8%) | 133 (52.8%) | 577 (57.4%) | p=0.390 | p=0.001 |
Female | 512 (50.3%) | 119 (47.2%) | 428 (42.6%) | ||
Risk factors required for the D'Agostino equation5 | |||||
n (%) | |||||
Non-smoker | 695 (68.2%) | 155 (61.5%) | – | p=0.646 | – |
Has diabetes | 313 (30.7%) | 68 (27.0%) | – | p=0.247 | – |
On antihypertensive drugs | 432 (42.4%) | 97 (38.5%) | – | p=0.260 | – |
Mean (SD) | |||||
Age | 60.5 (7.6) | 60.4 (7.3) | 61.3 (7.3) | p=0.915 | p=0.011 |
Systolic blood pressure (mm HG) | 141.1 (18.6) | 141.6 (18.9) | – | p=0.693 | – |
Total cholesterol (mmol/l) | 5.70 (1.02) | 5.45 (0.99) | – | p=0.001 | – |
HDL cholesterol (mmol/l) | 1.40 (0.39) | 1.35 (0.36) | – | p=0.047 | – |
10-year CVD risk at baseline | 0.115 (0.087) | 0.120 (0.093) | – | p=0.426 | – |
*χ2 tests conducted for categorical variables and t tests conducted for continuous variables.